42 results
Page 2 of 3
20-F/A
z5ghx9easc41atee2r0v
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
frrutgb3
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
g9bsqhrk fytvedt1
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
424B3
j7bmkq hirh38b
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
fsrfumlz a5s6w
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
2abbano2y2er8m
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
424B5
pu16qu sfomav4br65
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
wcvp2h5g
15 Oct 12
Prospectus supplement
12:00am
F-1
qpg x8xz5titzwj
2 Oct 12
Registration statement (foreign)
12:00am
424B3
vwwsvcc
28 Mar 12
Prospectus supplement
12:00am
20-F
ntl rwpmvzrvqwbql
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
bexm2n4xp9s19 rk
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-1
9ic17
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
20FR12B/A
dg4s311n x3
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
90twreab5m gsg
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
7ude9z2r
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am